Tasonermin
Beromun (tasonermin) is a protein pharmaceutical. Tasonermin was first approved as Beromun on 1999-04-12. It has been approved in Europe to treat sarcoma.
| Trade Name | Beromun |
|---|---|
| Common Name | Tasonermin |
| Indication | sarcoma |
| Drug Class | Growth factors: tumor necrosis factors |
